Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Bio-Techne Corp TECH

Healthcare  —  Biotechnology
72.61 0.04 0.06% as of 25 Sep
Market cap
$11.4B
P/E
62.1×
S&P 500 Member Dividend Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Bio-Techne Corp (TECH) P/E ratio

As of 25 September 2026, Bio-Techne Corp (TECH) trades at a P/E ratio of 62.1×. Over the past ten years it has ranged from 28.5× (January 2015) to 148× (September 2021); the current reading is higher than 62% of that period. That is above the Biotechnology industry median of 7.9× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2026 60.4× (46.01%)
FY2025 112× 65.56%
FY2024 67.6× 50.62%
FY2023 44.9× (10.20%)
FY2022 49.9× (59.73%)
FY2021 124× 181.83%
FY2020 44.0× (46.79%)
FY2019 82.7× 86.38%
FY2018 44.4× (26.36%)
FY2017 60.3× 50.19%

Quarterly

Period P/E ratio Change
Jun 2026 60.4× (17.96%)
Mar 2026 73.6× (34.92%)
Dec 2025 113× 1.65%
Sep 2025 111× (0.53%)
42 more quarters

Against its own ten years

Low 28.5× High 148×
Ten-year median 54.2×
Current reading's percentile 62

P/E ratio against peers

Company P/E ratio
BBIO BridgeBio Pharma, Inc. compare n/m
MDGL Madrigal Pharmaceuticals, Inc. compare n/m
SMMT Summit Therapeutics PLC compare n/m
AXSM Axsome Therapeutics, Inc. compare n/m
HALO Halozyme Therapeutics, Inc. compare 32.4×
KRYS Krystal Biotech, Inc. compare 41.9×
TECH Bio-Techne Corp 62.1×
BMRN BioMarin Pharmaceutical Inc. compare 159×
CORT Corcept Therapeutics Incorporated compare 223×
Biotechnology industry median 7.9×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on TECH